OBJECTIVE: This study aims to contribute to the collective experience with the treatment of those skull base tumors exceptionally arising in children and adolescents. MATERIALS AND METHODS: We retrospectively reviewed 42 patients younger than 19 years and operated on for a skull base tumor between 1992 and 2002. We analyzed data regarding patient age, histology, tumor location, extent of resection, postoperative complications, and adjuvant therapies. Long-term outcomes were also tracked (functional sequelae, recurrence, mortality). CONCLUSION: The median age was 13.75 years. Twenty-two patients harbored a malignant tumor. Gross total resection was achieved for 78% of cases. Transient postoperative cerebrospinal fluid leak or infection affected ten patients, suggesting the need for reconstructive techniques. Nineteen patients received adjuvant therapy. Recurrence rate was 47%. At the end of the follow-up (median = 63 months), 14% of patients had a neurological deficit and 30% were dead. Middle cranial base tumors were associated with a poor prognosis.
OBJECTIVE: This study aims to contribute to the collective experience with the treatment of those skull base tumors exceptionally arising in children and adolescents. MATERIALS AND METHODS: We retrospectively reviewed 42 patients younger than 19 years and operated on for a skull base tumor between 1992 and 2002. We analyzed data regarding patient age, histology, tumor location, extent of resection, postoperative complications, and adjuvant therapies. Long-term outcomes were also tracked (functional sequelae, recurrence, mortality). CONCLUSION: The median age was 13.75 years. Twenty-two patients harbored a malignant tumor. Gross total resection was achieved for 78% of cases. Transient postoperative cerebrospinal fluid leak or infection affected ten patients, suggesting the need for reconstructive techniques. Nineteen patients received adjuvant therapy. Recurrence rate was 47%. At the end of the follow-up (median = 63 months), 14% of patients had a neurological deficit and 30% were dead. Middle cranial base tumors were associated with a poor prognosis.
Authors: Douglas Brockmeyer; David P Gruber; Jeffrey Haller; Clough Shelton; Marion L Walker Journal: Pediatr Neurosurg Date: 2003-01 Impact factor: 1.162
Authors: Eugen B Hug; Reinhart A Sweeney; Pamela M Nurre; Kitty C Holloway; Jerry D Slater; John E Munzenrider Journal: Int J Radiat Oncol Biol Phys Date: 2002-03-15 Impact factor: 7.038
Authors: Ziv Gil; Snehal G Patel; Bhuvanesh Singh; Giulio Cantu; Dan M Fliss; Luiz P Kowalski; Dennis H Kraus; Carl Snyderman; Jatin P Shah Journal: Cancer Date: 2007-09-01 Impact factor: 6.860
Authors: Vafi Salmasi; Douglas D Reh; Ari M Blitz; Pedram Argani; Masaru Ishii; Gary L Gallia Journal: Childs Nerv Syst Date: 2011-10-29 Impact factor: 1.475
Authors: Matheus F M Ballestero; Stephanie N F de Souza; Romilto C Pacheco Neto; Guilherme G P Gondim; Elvis T Valera; Maristella B F Dos Reis; Benedicto O Colli; Ricardo S de Oliveira Journal: J Pediatr Neurosci Date: 2021-06-25